<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 11, 2000
----------------
DEXTERITY SURGICAL, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
- --------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-20532 74-2559866
- --------------------------------------------------------------------------------
(Commission File Number) (IRS Employer Identification No.)
12961 Park Central, Suite 1300, San Antonio, Texas 78216
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(210) 495-8787
- --------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
Not Applicable
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE> 2
Item 5. Other Events.
On January 11, 2000, Dexterity Surgical, Inc. (the "Company") announced
the attempted cancellation by United States Surgical of its General Surgical
Innovations, Inc. distribution agreement with the Company.
The Company's Press Release issued on January 11, 2000 announcing this
attempted cancellation is attached hereto as Exhibit 99.1 and incorporated by
reference herein.
Item 7. Financial Statements and Exhibits.
Exhibit Number Description
Exhibit 99.1 Press Release issued by Dexterity Surgical,
Inc. on January 11, 2000 (filed herewith)
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
DEXTERITY SURGICAL, INC.
By: /s/ RANDALL K. BOATRIGHT
-------------------------------------
Randall K. Boatright,
Executive Vice President,
Chief Financial Officer and Secretary
DATE: January 12, 2000
<PAGE> 1
EXHIBIT 99.1
Dexterity Surgical, Inc. Announces Company Developments
SAN ANTONIO, Jan. 11/PRNewswire/ -- Dexterity Surgical, Inc. (Nasdaq:DEXT)
announced today that United States Surgical, a division of Tyco Healthcare
Group LP, a Delaware Limited Partnership has attempted to cancel its
General Surgical Innovations, Inc. ("GSI") distribution agreement with
Dexterity related to balloon dissector, blunt tip trocar and tacker
products associated with minimal invasive hernia surgery. These products
accounted for approximately 50% of sales and 44% of gross profit of
Dexterity since the effective date of the distribution agreement.
Dexterity does not believe that United States Surgical has any right to
cancel the agreement and immediately plans to vigorously pursue its legal
remedies in the event negotiations between the parties are not successful.
Dexterity Surgical, Inc. is a leading designer, developer and distributor
of disposable and reusable devices, with a focus on the minimally invasive
surgical marketplace. The Company's goal is to provide focused segments of
the minimally invasive surgical marketplace with products that enhance
patient outcome, increase surgical flexibility and reduce health care
costs.
Certain statements contained herein are "forward looking" statements (as
such term is defined in the Private Securities Litigation Reform Act of
1995). Because such statements include risks and uncertainties, actual
results may differ materially from those expressed or implied by such
forward-looking statements. Factors that could cause actual results to
differ materially from those expressed or implied by such forward-looking
statements include, but are not limited to, those discussed in the
Company's Registration Statement on Form S-3 filed on October 30, 1998, and
the Company's annual and quarterly reports filed with the Securities and
Exchange Commission.
/CONTACT: Randy Boatright, CFO of Dexterity Surgical, Inc., 210-495-8787;
or Investor Relations: Ron Both, or Scott Liolios, 949-574-3860, both of
Liolios Group, Inc./
